The Shaw Group (SHAW) target raised at Goldman Sachs. Shares of SHAW now seen reaching $27, Goldman Sachs said. Improved execution, awards and catalysts prop shares near-term. Neutral rating.
Walgreen (WAG) estimates lowered at Guggenheim through 2012. No last ditch settlement with ESRX. Maintain $39 price target and buy rating.
Walgreen Company numbers lowered at Goldman Sachs. Shares of WAG now seen reaching $38, Goldman Sachs said. Estimates also lowered on poor quarter report. Buy rating.
>To submit a news tip, email: email@example.com.
Follow TheStreet on Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts